Feasibility, acceptability and change in health following a telephone-based cognitive behaviour therapy intervention for patients with axial spondyloarthritis by Pedley, Rebecca et al.
Original article
Feasibility, acceptability and change in health
following a telephone-based cognitive behaviour
therapy intervention for patients with axial
spondyloarthritis
Rebecca Pedley1, Linda E. Dean2, Ernest Choy 3, Karl Gaffney4,
Tanzeel Ijaz5, Lesley Kay6, Karina Lovell1, Christine Molloy1, Kathryn Martin2,
Jonathan Packham7,8, Stefan Siebert 9, Raj Sengupta 10,11,
Gary J. Macfarlane 2 and Rosemary J. Hollick 2
Abstract
Objective. The aim was to assess the feasibility and acceptability of a telephone-based cognitive be-
haviour therapy (tCBT) intervention for individuals with axial SpA (axSpA), with and without co-morbid
FM, and to measure the change in patient-reported health outcomes.
Methods. A convenience sample of individuals recruited from British Society for Rheumatology Biologics
Registry for AS (BSRBR-AS) sites were offered a course of tCBT (framed as coaching). Patient-reported out-
comes were measured at baseline and on course completion. Semi-structured qualitative interviews assessed
intervention acceptability. Thematic analysis was informed by the theoretical framework of acceptability.
Results. Forty-two participants attended for initial assessment. Those completing at least one tCBT ses-
sion (n¼ 28) were younger, more likely to meet classification criteria for FM (57 vs 29%) and reported
higher disease activity. Modest improvements were reported across a range of disease activity and wider
health measures, with 62% of patients self-rating their health as improved (median 13 weeks post-
intervention). Twenty-six participants were interviewed (including six who discontinued after initial assess-
ment). tCBT was widely acceptable, offering a personalized approach. Despite low or unclear expectations,
participants described improved sleep and psychological well-being and gained new skills to support self-
management. Reasons for non-uptake of tCBT centred on lack of perceived need and fit with individual
value systems. Many felt that tCBT would be most useful closer to diagnosis.
Conclusion. Higher uptake among axSpA patients with co-morbid FM suggests that these individuals
have additional needs. The findings are helpful in identifying patients most likely to engage with and
benefit from tCBT and to maximize participation.
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Introduction
FM is a common co-morbidity in patients with axial SpA
(axSpA). Compared with a 2–4% population prevalence
of FM using ACR 1990 classification criteria, a recent
meta-analysis estimated that the prevalence of FM in
axSpA patients was 13% [1]. Within the British Society
of Rheumatology Biologics Registry for AS (BSRBR-AS),
one in five patients met 2011 research criteria for FM
[2]. AxSpA patients with co-morbid FM have a higher
disease activity and worse quality of life (QoL) than
those without FM [2–6]. Although meeting FM criteria is
partly a reflection of high disease activity, it is specifi-
cally a high somatic symptom burden that primarily pre-
dicts an attenuated response to TNFi therapy [7, 8].
Effective strategies are needed to manage both in-
flammatory disease and co-morbid FM. Cognitive be-
haviour therapy (CBT) improves coping with pain and
depressed mood [9] in FM, and the benefits are sus-
tained over time. Our recent randomized controlled trial
of telephone-delivered CBT (tCBT) and a community ex-
ercise programme for chronic widespread pain found
clinically significant improvements in patient-reported
health outcomes both at the end of a course of therapy
[10] and 2 years later [11]. tCBT has also been shown to
be cost effective [11], acceptable [12] and with improved
adherence compared with face-to-face delivery [13].
However, whether the benefit of such therapy is specific to
(or greatest in) patients with FM and axSpA or is more gener-
ally beneficial to patients with axSpA only is not known. Lack
of engagement with CBT-based interventions is also prob-
lematic. Even when participants have agreed to take part in
studies that include a CBT component, around one-third of
patients do not engage [10]. Qualitative studies, exploring
experiences of tCBT for the treatment or prevention of
chronic widespread pain, have included only participants
with experience of the intervention, omitting those who did
not take up tCBT [12, 14]. The reasons for lack of uptake
therefore remain unclear. Understanding acceptability is im-
portant to encourage recipients to engage fully with and ben-
efit from new interventions [15].
The aim of this study was to assess the feasibility, ac-
ceptability and change in patient-reported health meas-
ures after a 6-week tCBT intervention for axSpA
patients, with and without co-morbid FM. We also ex-




The Fibromyalgia Optimal Management for patients
with Axial Spondyloarthritis (FOMAxS) study examined
the co-occurrence of axSpA and FM in persons who
met the Assessment of SpondyloArthritis international
Society (ASAS) criteria for axSpA. Participants from
the BSRBR-AS study who had given consent to be
contacted regarding other studies were eligible. In ad-
dition, patients from other centres who met BSRBR-
AS eligibility criteria were eligible.
A convenience sample of FOMAxS participants were in-
vited to take part in a tCBT intervention. Given that 30
participants is thought to represent an adequate sample
size for an acceptability study [16], we aimed to recruit
15 participants who met the 2011 research criteria for
FM and 15 who did not. Based on the tCBT intervention
in the Managing Unexplained Symptoms In primary Care:
Involving traditional and Accessible New approaches
(MUSICIAN) trial [10], the study intervention included an
initial assessment (45–60 min), followed by six weekly
one-to-one sessions (30 min each). This was delivered re-
motely by a psychological well-being practitioner (PWP)
and supported by a CBT-based manual. PWPs undertake
accredited training in improving access to psychological
therapies (in this case, a postgraduate certificate for ad-
vanced interventions in mental health) and support people
with common mental health problems within the NHS.
The PWP (C.M.) had 4 years of experience in delivering
CBT-based treatments. Although treatment fidelity was
not assessed formally, adherence to the overall approach
was ensured through training and clinical supervision from
K.L., author of the coaching manual.
Intervention content
The intervention was described to participants as
coaching sessions, after feedback from a National Axial
Spondyloarthritis stakeholder consensus meeting.
Patients felt very strongly that the word therapy had a
number of negative connotations within society, whereas
the term coaching implied a more positive, active self-
management approach that was more empowering.
Individuals stressed their preference for a flexible ap-
proach and multiple tools (a tool kit) to help self-manage
their axSpA and support them to react/adapt and man-
age what the day brings; every day, disease or not.
Patients felt that the concept of coaching fitted well with
Key messages
. Higher uptake of telephone-based cognitive behaviour therapy among axial SpA patients meeting criteria for FM
suggests that they have additional needs.
. Telephone-based cognitive behaviour therapy might be of most benefit close to diagnosis.
. Acceptability of telephone-based cognitive behaviour therapy is enhanced by framing the intervention as coaching.
. Despite low expectations, participants reported modest short-term improvements in health outcomes.
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this. The FOMAxS intervention was personalized, and
consequently, the cognitive behavioural and behavioural
change techniques (BCTs) used varied depending on the
participant’s goal(s). However, BCTs were used generally
throughout the sessions to enable the participant to gain
the most benefit from the intervention and the activities
they carried out between sessions. This included setting
goals, planning how to achieve these goals, self-
monitoring and reviewing progress towards goals, and
modifying or setting new goals after review.
A list of BCTs used across the intervention using the
taxonomy of techniques from Michie et al. [17] is pro-
vided in Supplementary Table S1, available at
Rheumatology Advances in Practice online, and a
Template for Intervention Description and Replication
TIDieR checklist [18] in Supplementary Table S2, avail-
able at Rheumatology Advances in Practice online.
Patient-reported outcomes
Baseline and follow-up questionnaires self-administered
before commencing the course and after completion in-
cluded sociodemographic factors and lifestyle factors
(physical activity). Health-related quality of life was
assessed by the AS Quality of Life index [ASQoL:
scored from 0 (best) to 18 (worst)] [19], mental health by
the Hospital Anxiety and Depression Scale [HADS: from
0 (best) to 21 (worst)] [20], fatigue by the Chalder
Fatigue Scale [scored from 0 (best) to 11 (worst)] [21]
and sleep disturbance by the Jenkins Sleep Evaluation
Questionnaire (0–20) [22]. Spinal pain was assessed us-
ing a 10 cm visual analog scale, and Bath indices of dis-
ease activity (BASDAI) and function (BASFI) [scored
from 0 (best) to 10 (worst)] [23, 24]. The 2011 research
criteria for FM provided both widespread pain index and
symptom severity scores (0–19 and 0–12, respectively,
with higher scores indicating poorer states) [25].
Physical activity was assessed by the number of
minutes spent walking (per day) and engaging in moder-
ate or vigorous physical activity (per week) using ques-
tions included in UK Biobank. Follow-up questionnaires
additionally included a single item in which participants
rated the change in their health since the period before
receiving tCBT (categorical item response: very much
better, much better, a little better, no change, a little
worse, much worse or very much worse).
Acceptability and experiences of tCBT
All participants offered tCBT, including those who sub-
sequently declined or discontinued treatment, were in-
vited to take part in a qualitative telephone interview, up
to the point of data saturation. The interviewer was not
involved in delivery of the intervention. Interviews were
conducted as soon as possible after the final coaching
session or study withdrawal. Interviews explored expect-
ations, perceived outcomes and perceptions of the
intervention, and reasons for non-uptake or discontinua-
tion. Interviews were recorded using an encrypted voice
recorder and transcribed.
Data analysis
Participants were described in terms of sociodemo-
graphic and patient-reported factors [proportions for
categorical factors and median and inter-quartile range
(IQR) for continuous factors]. Among those who received
tCBT, the absolute changes in patient-reported meas-
ures (median time between baseline and follow-up ques-
tionnaires 13 weeks) were calculated (follow-up minus
baseline score) and are presented as the median and
IQR. Participants who rated the change in their health
as being very much better, much better or a little better
were considered to have improved since the period be-
fore receiving tCBT.
Interview transcripts were analysed using thematic
analysis [26]. Inductive and deductive coding was un-
dertaken using NVivo software (v.12 Pro), guided by the
theoretical framework of acceptability (TFA) [15]. This
incorporates seven constructs: ethicality, burden, coher-
ence, self-efficacy, affective attitude, perceived effec-
tiveness and opportunity costs (Table 1). Analysis was
refined through regular meetings with a second re-
searcher and wider discussions with the study team.
Emerging themes were discussed with two patient
groups convened by the National Axial Spondyloarthritis
Society before finalization and write-up.
The BSRBR-AS received ethical approval from the
National Research Ethics Service Committee North East
– County Durham and Tees Valley (reference 11/NE/
0374). Ethical permission for the FOMAxS study was
granted by the South East Scotland Research Ethics
Committee 1 (18/SS/0020). Written consent was
obtained from participants before any study-related pro-
cedures were conducted.
Results
Forty-seven individuals were approached to participate
in tCBT. Five were subsequently unable to be contacted
to arrange initial assessment; therefore, 42 individuals
received an initial tCBT assessment (via telephone).
Fourteen individuals did not subsequently wish to pro-
ceed with a course of tCBT or reached an agreement
with the coach that they did not require tCBT (hereafter
termed non-engagers). Twenty-eight participants com-
pleted at least one tCBT session (hereafter termed
engagers), of whom 17 (61%) participated in the full six
sessions [median number of sessions 6 (IQR 3.5, 6)].
Engagers were younger than non-engagers [median age
of 59 (IQR 49, 70) vs 69 years (51, 74)], with more co-
morbid FM (57 vs 29%) and higher disease activity
[BASDAI 5.6 (IQR 2.4, 7.0) vs 3.4 (1.2, 5.8)].
More than two-thirds of engagers were educated be-
yond secondary school, and approximately one-third were
in full time employment. Forty-one per cent were female,
with a median disease duration of 36 years (IQR 12, 48)
(Table 2). At baseline, engagers reported moderate levels
of spinal pain [median 5.0 (IQR 2.0, 7.8)], health-related
quality of life [8.0 (3.0, 11.0)], fatigue [3.5 (1.5, 7.0)],
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depression [4.0 (2.5, 8.0)] and anxiety [9.0 (5.0, 12.5)] but
poor disease activity, physical function and sleep distur-
bance scores [BASDAI: 5.6 (2.4, 7.0); BASFI: 5.1 (2.1, 7.2);
Jenkins: 10.5 (5.5, 16.0)]. Median widespread pain and
symptom severity scores for this group were 6.0 (2.0,
11.0) and 6.0 (4.0, 10.0), respectively.
Sixty-two per cent of engager patients self-rated their
health as improved (median 13 weeks post intervention;
Table 3). There were no significant differences in out-
come between those who met criteria for FM and those
who did not; therefore, combined results are presented.
Engagers generally reported a median one point reduc-
tion across a range of disease-specific and general
health measures: spinal pain [median 1.0 (IQR 1.5,
0.0)], disease activity [0.9 (1.5, 0.2)], fatigue [1.0
(2.0, 0.0)], sleep disturbance [1.0 (3.0, 1.0)], anxiety
TABLE 1 Definitions of the seven constructs of the theoretical framework of acceptability (reproduced from Sekhon et al.
[15])
Theoretical Framework of acceptability (TFA) Definition
Ethicality The extent to which the intervention has a good fit with an individu-
al’s value system
Affective attitude How an individual feels about the intervention, after taking part
Burden The amount of effort that was required to participate in the
intervention
Opportunity costs The benefits, profits or values that were given up to engage in the
intervention
Perceived effectiveness Experienced effectiveness: the extent to which the intervention is
perceived to have achieved its intended purpose
Self-efficacy The participant’s confidence that they can perform the behaviour(s)
required to participate in the intervention
Intervention coherence The extent to which the participant understands the intervention
and how it works
TABLE 2 Baseline descriptors of those offered CBT and who attended at least one session (n¼ 28)
Baseline factors Frequency Percentage/median (IQR)
Age 28 59 (49, 70)
Gender Female 11 40.7
Male 16 59.3
Education Secondary school 6 24.0
Apprenticeship/college 10 40.0
University/further education 9 36.0
Employment Full-time/unpaid 9 34.6
Part-time 5 19.2
Retired 9 34.6
Retired/unemployed (owing to health) 3 11.5
Prescribed a biologic DMARD? Yes 13 48.2
No 14 51.8
Disease durationa Years 25 36 (12, 48)
Physical activity Minutes of walking/day 25 60 (25, 120)
Days with moderate physical activity/week 25 4 (2, 7)
Days with vigorous physical activity/week 26 2 (0, 4)
Spinal pain VAS 0 (best)–10 (worst) 26 5.0 (2.0, 7.8)
Disease activity BASDAI: 0 (best)–10 (worst) 26 5.6 (2.4, 7.0)
Functional impairment BASFI: 0 (best)–10 (worst) 25 5.1 (2.1, 7.2)
Quality of life ASQoL: 0 (best)–18 (worst) 23 8.0 (3.0, 11.0)
Fatigue CFS: 0 (best)–11 (worst) 24 3.5 (1.5, 7.0)
Sleep disturbance Jenkins: 0 (best)–20 (worst) 24 10.5 (5.5, 16.0)
Anxiety HADS: 0 (best)–21 (worst) 24 9.0 (5.0, 12.5)
Depression HADS: 0 (best)–21 (worst) 24 4.0 (2.5, 8.0)
Widespread pain index 0 (best)–19 (worst) 21 6.0 (2.0, 11.0)
Symptom severity score 0 (best)–12 (worst) 25 6.0 (4.0, 10.0)
aYears from symptom onset to screening visit. ASQoL: AS Quality of Life Index; CBT: cognitive behavioural therapy; CFS:
Chalder Fatigue Scale; HADS: Hospital Anxiety and Depression Scale; IQR: inter-quartile range; VAS: visual analog scale.
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levels [1.0 (3.0, 1.0)] and widespread pain index
[1.0 (2.0, 0.0)]. Smaller median improvements were
noted for both physical function and FM symptom
severity [0.3 (0.7, 0.1) and 0.5 (1.5, 1.0), respec-
tively], and there was no median change in quality of life
[0.0 (2.0, 1.0)] or depression levels [0.0 (2.0, 1.0)].
Acceptability and experiences of tCBT
Twenty-six participants consented to be interviewed, in-
cluding 6 non-engagers and 20 engagers. Of these,
35% were female, with a median age of 63 years and
disease duration of 37 years. Thirty-eight per cent met
criteria for FM. Emergent themes included all but one
construct of the TFA (opportunity costs), plus an addi-
tional emergent theme (perceived need).
Perceived need: variability in perceived need
influenced uptake of the intervention
A common reason for non-uptake of coaching was that
symptoms or impacts of axSpA were perceived as man-
ageable at the time of assessment. Access to good
health care, supportive friends and family, keeping ac-
tive and eating well supported self-management. After
undertaking assessment, the following individual made a
decision with his coach to discontinue:
I don’t think I can get any better than I am, put it that way, like, I’m
okay, I’m up and running. . ..
Patient 14, male, zero sessions.
Others dismissed ongoing symptoms as normal for
their age:
. . .whether it’s down to just getting old or whether it’s down to the
AS I really don’t know. I would always assume it’s with just getting
older.
Patient 6, male, zero sessions.
Many felt that tCBT would have been most beneficial
earlier in their condition, when they had struggled most
to cope with their illness. Receiving tCBT many years af-
ter illness onset felt too late for some, either because
they saw the illness as unmodifiable or because they al-
ready felt able to cope. The following participant de-
scribed some benefits but felt there was nothing more
to address after two sessions:
. . .I feel this programme’s been well set up, but it is something peo-
ple who are just being diagnosed with AS should have, and not me
as an old-stager who’s worked her way through it and sorted out
what’s what.
Patient 8, female, two sessions.
Participants identified people who they perceived
would be most likely to benefit from tCBT, such as
those in more pain, people with mental health problems
and those lacking social support:
. . .if I’d have been maybe in my mid-40s, completely housebound
and depressed, I could see that the coaching might be of help. But
I’m not.
Patient 10, male, zero sessions.
In some, cases however, participants who initially per-
ceived themselves to have low need changed their opin-
ion after further discussion about how coaching might
be able to help:
. . .because obviously I knew I didn’t suffer that much with AS. I,
kind of, wondered what we were going to talk about through the
sessions, and it was only, I think it was only during that first session
when we, sort of, really hit on the sleep side of things that things,
sort of, clicked for me. I realized that’s good, I can probably help
you and you can probably help me. . .
Patient 11, male, six sessions.
There was also an admission among some that even
though the treatment would have been more helpful ear-
lier in the course of their condition, it had still proved
highly valuable:
TABLE 3 Patient-reported outcome change among those offered CBT and attending at least one session (n¼ 22)
Frequency Percentage




Absolute change in: Frequency Median (IQR)
Spinal pain VAS 20 1.0 (1.5, 0.0)
Disease activity (BASDAI) 20 0.9 (1.5, 0.2)
Functional impairment (BASFI) 19 0.3 (0.7, 0.1)
Quality of life (ASQoL) 15 0.0 (2.0, 1.0)
Fatigue (CFS) 18 1.0 (2.0, 0.0)
Sleep disturbance (Jenkins) 18 1.0 (3.0, 1.0)
Anxiety (HADS) 18 1.0 (3.0, 1.0)
Depression (HADS) 18 0.0 (2.0, 1.0)
Widespread pain index 13 1.0 (2.0, 0.0)
Symptom severity score 20 0.5 (1.5, 1.0)
ASQoL: AS Quality of Life Index; CFS: Chalder Fatigue Scale; HADS: Hospital Anxiety and Depression Scale; IQR: inter-
quartile range; VAS: visual analogue scale.
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. . .hit the target area before they’re diagnosed or when they’re first
diagnosed, that’s the only thing I would . . . (change).. . . But having
said that, if you look at the likes of me, if I hadn’t have been in-
cluded in the study group, I would still be a grumpy old man who
wasn’t getting proper sleep.. . ..
Patient 9, male, six sessions.
Ethicality: the extent to which the intervention has a
good fit with an individual’s value system
Stoicism and a belief in self-sufficiency contributed to a
perceived lack of need for tCBT and influenced deci-
sions to take part:
I don’t feel that I am in that much of pain . . . discomfort that I want
to discuss it with someone on the end of the phone, that it’s going
to help me in any way.. . . I just tend to deal with it myself. I’m prob-
ably old school . . . at the end of the day, I have still got to get up
and go to work.
Patient 12, male, zero sessions.
In contrast, having an open attitude to managing
axSpA facilitated engagement. Use of the term coaching
rather than therapy helped some to overcome precon-
ceived ideas about CBT:
. . .from somebody who’s always tried to work and, I guess, go
through the pain and carry on life as normal, the idea of coaching
appealed to me a lot more, because it sounded like something
more practical. And less emotional, but it ended up being a bit of
both, which is good.. . .
Patient 13, female, six sessions.
Burden: amount of effort required to participate in
the intervention
A telephone-based approach was viewed as convenient,
reducing time, stress and physical exertion associated
with attending appointments face to face. Engaging by
telephone helped participants to feel more relaxed and
anonymous than they would do in a face-to-face clinical
setting:
. . .I can get in the house, sit on my chair. I’m in my own little sur-
roundings, so I’m relaxed and talking to a perfect stranger on the
phone about my health problems. . ..
Patient 9, male, six sessions.
This was enhanced by the coach, regarded as calm
and easy to talk to. Flexible scheduling of appointments
enabled participants to fit sessions around other com-
mitments. For most, weekly sessions were regular
enough to maintain momentum while allowing time to
carry out homework. The coach ensured that tasks were
clear and achievable:
. . .she [coach] broke it down into the bite sizes. And so that was
easy to absorb during the week, and that made the whole thing
easier to think, oh yes, actually, that’s been quite good. I can keep
that going.. . .
Patient 4, female, six sessions.
In contrast, one participant felt that the demands of
tCBT were too great given other issues in their life.
Coherence: the extent to which the participant
understands the intervention and how it works
Many participants were unsure what tCBT would involve
or whether it would help, but were pleasantly surprised
to find it beneficial:
I don’t know how you could get it across to them that this really is
good because, like I said, I thought it would just be solely talking
about AS but it wasn’t. It was talking about me with AS.
Patient 1, female, six sessions.
A lack of understanding about how tCBT might help
participants reduced acceptability. For example, one
participant struggled to see the relevance of poor sleep
to his condition and would have preferred support that
he perceived would more clearly address his physical
symptoms:
That was the only thing that was getting me down a bit, [coach]
kept asking me about the sleep pattern and all this and that, and I
thought it would have been more, say, something I can do to, you
know, like exercise or whatever, you know. Why are they on about
the sleep pattern? I don’t know.
Patient 7, male, five sessions.
However, most participants’ understanding of how
tCBT worked developed through experience; seeing the
value of having someone to help them develop new
ways of managing their condition and the ability to look
at it in a different light.
Self-efficacy: the participant’s confidence that they
can perform the behaviour(s) required to participate
in the intervention
A number of features of tCBT supported participation
and increased confidence. The quality of the working re-
lationship with the coach was important. The ability of
the coach to listen, be non-judgmental and respectful,
provide encouragement and reassurance and demon-
strate flexibility in adapting approaches according to in-
dividual needs, preferences and context were important.
The anonymity of telephone delivery enhanced the
ability of participants to be open and honest:
. . .speaking to someone about things that are quite personal but
having never met them was initially a bit disconcerting, but then I
felt quite safe, like, well she doesn’t even know what I look like, she
doesn’t even know where I am right now, I can say whatever I
want.. . .
Patient 13, female, six sessions.
Although a number of theoretical concerns about
tCBT were expressed (e.g. loss of visual cues impeding
communication), in reality most reported being able to
engage well with tCBT.
Most regarded the tCBT manual as informative and
accessible. Many participants identified and used sec-
tions they could relate to, such as the case studies.
However, some found reading the manual a struggle
(preferring contact with the coach). Suggested improve-
ments included better illustrations and greater diversity
in the case studies, particularly in gender balance.
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Occasionally, other physical health problems reduced
the ability of participants to engage. Participants
expressed regret that symptoms such as breathlessness
and stomach problems made it difficult for them to en-
gage in the exercises that they wanted to do, thus
restricting their physical activity.
Affective attitude: how an individual feels about the
intervention after taking part
Participants expressed positive views about tCBT, which
offered more time and opportunity to get to the nitty
gritty compared with usual medical appointments:
. . .when I go to hospital for my annual check-ups to see the consul-
tant, have them measure, look at my flexibility, that sort of thing,
and don’t really get nothing out of it, if that makes sense. Thanks
for coming, you’re still quite flexible, you’re still fairly young, it’s not
really giving you any problems in your life, we’ll see you in a year.
Whereas at least with [coach name] it was talking around it all,
around how it makes me feel outside of work, how it makes me feel
at work and then probably what help was there. . .
Patient 2, male, six sessions.
Participants valued the fact that tCBT took a holistic
approach:
Your body, yes, you can manage that. But it’s your mind that has to
cope with it all. And to have a pathway open for you, as I did with
[coach name], I think has made such a tremendous difference. . .
Patient 5, female, six sessions.
Most participants felt that the number, spacing and
duration of tCBT sessions was sufficient. Those with
lower perceived need sometimes found that fewer than
six sessions were required, whereas a small number felt
they might have benefitted from more sessions. Some
suggested that booster sessions would be helpful to im-
prove confidence and to check that they were managing
to implement the tools/skills learned.
Perceived effectiveness: the extent to which the
intervention is perceived to have achieved its
intended purpose
Most felt that tCBT brought significant benefits to their
health, well-being and quality of life. Only a small num-
ber felt that nothing had changed. Setting and reviewing
goals helped to motivate and overcome barriers to be-
haviour change:
. . .we can all put barriers in front of ourselves, can’t we, around why
we can’t do it or why we decide not to do it. So that was quite
good, having someone give me a bit of pressure around the goals I
was setting and why I wasn’t doing them. . .
Patient 2, male, six sessions.
The ability of participants to self-manage their axSpA
reportedly improved in a number of different ways; pac-
ing of activities, encouraging practical steps to manage
symptoms (e.g. purchasing new pillows, driving mirrors)
and greater confidence about advocating for their needs
in the workplace (e.g. speaking to their manager about
reducing repetitive tasks). Improvements to mood and
motivation and reduced guilt, worry and irritability were
commonly reported:
. . .it’s definitely more mentally helpful . . . at the beginning I felt a bit
more alone, a little bit trapped. And, I think, part of the guilt of talk-
ing about it or saying something is knowing that other people have
a lot going on in their lives. So, speaking to [coach name] was very
selfish time.. . .
Patient 13, female, six sessions.
Participants also reported that tCBT helped to facili-
tate changes to broader aspects of health and well-
being, such as losing weight, improving diet, social
functioning and relationships, by developing knowledge,
skills and coping mechanisms that they continued to
use beyond the sessions:
. . .it’s been fantastic, because now, instead of sitting here, thinking,
right, and getting stressed out, I sort of can help myself a bit.
Patient 3, female, six sessions.
Discussion
Individuals with axSpA, with and without FM, who par-
ticipated in a 6-week tCBT programme reported mod-
est, although not clinically significant, improvements
across disease-specific and more general health meas-
ures 3 months after starting the programme. Those
without co-morbid FM were less likely to engage with
tCBT. Non-engagers reported low perceived need for
tCBT and stoicism, and might have determined accu-
rately that they had no need for it. In contrast, other par-
ticipants, including some who were initially sceptical or
unclear at the outset regarding the potential benefits of
tCBT, subsequently found it useful and relevant. Among
engagers, tCBT was widely acceptable, providing a ho-
listic approach that participants thought was unavailable
elsewhere, and provided skills and resources that pro-
moted self-management. However, many participants
felt that tCBT would have been most useful closer to
diagnosis.
Interviews with a diverse sample of individuals (age,
gender, presence or absence of FM, number of tCBT
sessions completed), in addition to the inclusion of par-
ticipants who did not take up tCBT, ensured that the
dataset was not restricted to the views of individuals
who found tCBT acceptable; the exclusion of those dis-
continuing tCBT is a limitation of previous acceptability
studies [12].
However, our study has some limitations. The main
aim of this study was to examine the feasibility and ac-
ceptability of a tCBT intervention, rather than to mea-
sure the effectiveness of treatment. We did not examine
whether or not reported health benefits were maintained
or increased over time, and formal evaluation of effec-
tiveness will require a randomized controlled trial.
Although treatment effectiveness was not the focus of
this study, it is important in shaping experiences of
treatment and acceptability. Yet despite initial scepti-
cism and lack of clarity about its potential effectiveness,
and modest short-term improvements in health
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outcomes, most participants still found the intervention
useful, relevant and acceptable.
The intervention was delivered by a single coach ex-
perienced in delivering tCBT and who was employed
specifically to deliver tCBT as part of the study.
Perceptions of tCBT might differ in routine clinical set-
tings. Telephone-based intervention and interviews
might have presented a barrier to participation for those
with communication difficulties. However, in light of the
current COVID-19 pandemic, tCBT provides a safe and
accessible means of intervention delivery.
The intervention was offered to everyone, and it is
therefore possible that some participants received a treat-
ment they did not need. However, there is no strong evi-
dence base to predict precisely who benefits most from
CBT. There was higher uptake of tCBT among those
axSpA patients meeting criteria for FM, suggesting that
these individuals have additional needs. Participants pre-
dominantly had established as opposed to early disease,
and our findings suggest that tCBT might be more benefi-
cial closer to diagnosis. Likewise, engagers had higher
disease activity than non-engagers, suggesting that tar-
geting individuals with moderate/high disease activity
might improve engagement. However, a number of indi-
viduals with low perceived need at the outset subse-
quently found it beneficial as their understanding of the
intervention developed; previously unmet needs were
identified, and unanticipated benefits emerged.
Individuals with and without co-morbid FM reported
modest improvements in health measures after tCBT.
Although these modest benefits were not clinically sig-
nificant, they are consistent with the benefits of tCBT
reported elsewhere, which have been shown to increase
with time and translate into longer-term improvements in
quality of life and cost-effectiveness [11].
Interestingly, those receiving tCBT reported higher
anxiety scores compared with depression scores at
baseline, and many participants recalled heightened
anxiety, especially around the time of initial diagnosis.
axSpA patients with anxiety and depression report
poorer quality of life and global health, greater fatigue
and higher disease activity [27]. CBT-informed
approaches have proven efficacy in the treatment of
anxiety disorders [28] and might be particularly helpful
for individuals with prominent anxiety. Our recent
studies evaluating the acceptability of tCBT for the
those with chronic widespread pain also found tCBT
to be helpful, despite some initial scepticism about its
benefits and lack of understanding of how a psycho-
logical intervention could improve a physical condition
[12, 14]. Stoicism and self-reliance have been shown
to have a negative influence on the attitudes of older
adults to psychotherapy [29] and might have been
more prevalent in this older study group with long-
standing disease.
The TFA [15] sensitized the analysis to important
aspects of acceptability. Emergent themes mapped
onto a number of constructs of the framework (ethicality,
burden, coherence, self-efficacy, affective attitude and
perceived effectiveness). However, perceived need
emerged as a separate construct, shaping acceptability
of the tCBT intervention in a number of ways; influencing
initial decisions to engage with the intervention and
changing over time as participants’ understanding of the
intervention developed, unmet needs were identified and
previously unanticipated benefits emerged. Future stud-
ies should consider whether perceived need emerges in
evaluations of acceptability across other conditions,
suggesting a need to incorporate it as a construct within
the TFA.
Our study findings are helpful in identifying patients
who might benefit most from tCBT and informing
approaches to improve engagement. tCBT might be of
greater benefit to those more recently diagnosed with
axSpA who have particular information needs [30]. Such
patients are also more likely to be younger and of work-
ing age. We have previously shown that the ability to
participate in work is important for people with axSpA
[31], and future studies should consider the cost–benefit
more widely in terms of gains in ability to work.
Reasons for non-uptake of tCBT centred on a lack of
perceived need and lack of fit with their value system,
rather than dissatisfaction with other aspects of the inter-
vention. Our patient partners felt that framing the tCBT in-
tervention as coaching rather than therapy conveyed a
more positive, active self-management approach that
might also be helpful to support self-management in other
rheumatic diseases and in long-term conditions more
broadly. Likewise, creating resources (such as the manual)
and providing participants with brief case studies that
showcase the array of difficulties tCBT can address might
help to overcome unhelpful preconceptions and promote
engagement. Flexibility in session delivery and the provi-
sion of booster sessions might facilitate ongoing engage-
ment and support for self-management.
In conclusion, this study provides promising evidence
of the acceptability and benefit of tCBT for patients with
axSpA. Future testing to assess the clinical effectiveness
and cost-effectiveness of tCBT in axSpA and other
rheumatic diseases should draw on learning from this
study, in particular how best to identify and target indi-
viduals most likely to engage and benefit and how to
maximize participation.
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